Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Nordic 2023 guidelines for the diagnosis and treatment of lung neuroendocrine neoplasms.
Department of Hepatology & Gastroenterology, ENETS Center of Excellence, Aarhus University Hospital, & Department of Clinical Medicine, Aarhus University, Aarhus, Denmark..
Department of Hepatology & Gastroenterology, ENETS Center of Excellence, Aarhus University Hospital, & Department of Clinical Medicine, Aarhus University, Aarhus, Denmark..
Division of Oncology, Department of Clinical Sciences Lund, Lund University, Sweden..
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Immunology, Genetics and Pathology.ORCID iD: 0000-0003-2226-3517
Show others and affiliations
2023 (English)In: Acta Oncologica, ISSN 0284-186X, E-ISSN 1651-226X, Vol. 62, no 5, p. 431-437Article in journal (Refereed) Published
Abstract [en]

Lung neuroendocrine neoplasms (NEN) are a heterogeneous population of neoplasms with different pathology, clinical behavior, and prognosis compared to the more common lung cancers. The diagnostic work-up and treatment of patients with lung- NEN has undergone major recent advances and new methods are currently being introduced into the clinic. These Nordic guidelines summarize and update the Nordic Neuroendocrine Tumor Group's current view on how to diagnose and treat lung NEN-patients and are meant to be useful in the daily practice for clinicians handling these patients. This review reflects our view of the current state of the art of diagnosis and treatment of patients with lung-NEN. Small cell lung carcinoma (SCLC) is not included in these guidelines.

Place, publisher, year, edition, pages
Informa UK Limited Taylor & Francis, 2023. Vol. 62, no 5, p. 431-437
Keywords [en]
Lung, bronchopulmonary neoplasm, diagnosis, neuroendocrine carcinoma, neuroendocrine neoplasm, treatment
National Category
Cancer and Oncology Respiratory Medicine and Allergy
Identifiers
URN: urn:nbn:se:uu:diva-505319DOI: 10.1080/0284186X.2023.2212411ISI: 000990174700001PubMedID: 37194281OAI: oai:DiVA.org:uu-505319DiVA, id: diva2:1770339
Available from: 2023-06-19 Created: 2023-06-19 Last updated: 2024-12-03Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMed

Authority records

Botling, JohanSundin, AndersWelin, StaffanTiensuu Janson, Eva

Search in DiVA

By author/editor
Botling, JohanSundin, AndersPetersen, Rene HorslebenWelin, StaffanTiensuu Janson, EvaLanger, Seppo W.
By organisation
Department of Immunology, Genetics and PathologyRadiologyEndocrine Oncology
In the same journal
Acta Oncologica
Cancer and OncologyRespiratory Medicine and Allergy

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 70 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf